Aeon Biopharma Class A (AEON) closed at $0.15 on November 13, 2026, down 3.8% from the previous close, on volume of 761,942 shares (30-day average 1,099,468).
Data as of November 13, 2026.
AEON Biopharma Submits IND for Comparative Pharmacodynamic Study of ABP-450
Globe Newswire (Mon, 9-Nov 8:00 AM ET)
AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
Globe Newswire (Fri, 9-Oct 4:15 PM ET)
AEON climbs as FDA Type 2b feedback supports a potentially streamlined ABP-450 biosimilar path
Market Chameleon (Wed, 30-Sep 7:36 AM ET)
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450
Globe Newswire (Wed, 30-Sep 8:00 AM ET)
Globe Newswire (Wed, 9-Sep 8:00 AM ET)
Globe Newswire (Mon, 31-Aug 8:00 AM ET)
Market Chameleon (Tue, 25-Aug 6:31 AM ET)
Globe Newswire (Mon, 24-Aug 8:00 AM ET)
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX
Globe Newswire (Wed, 19-Aug 8:00 AM ET)
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.
As of November 13, 2026, AEON stock price declined to $0.15 with 761,942 million shares trading.
AEON has a beta of 1.45, meaning it tends to be more sensitive to market movements. AEON has a correlation of 0.02 to the broad based SPY ETF.
AEON has a market cap of $9.04 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, AEON traded as high as $1,236.24 and as low as $.13.
The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.
AEON has underperformed the market in the last year with a price return of -83.2% while the SPY ETF gained +11.5%. AEON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -44.4% and -48.0%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
AEON support price is $.15 and resistance is $.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.
